{Reference Type}: Case Reports
{Title}: A case report of cystoid macular edema, uveitis and vitreomacular traction in a patient taking Anastrozole.
{Author}: Nguyen KH;Smith AK;Kim BT;Browne AW;Nguyen KH;Smith AK;Kim BT;Browne AW;
{Journal}: Am J Ophthalmol Case Rep
{Volume}: 25
{Issue}: 0
{Year}: Mar 2022
暂无{DOI}: 10.1016/j.ajoc.2022.101339
{Abstract}: <B>OBJECTIVE: </B>To report a case of cystoid macular edema, uveitis, and vitreomacular traction in a patient with a history of breast cancer and taking anastrozole.<BR><B>METHODS: </B>A 73-year-old female with a history of estrogen receptor-positive breast cancer and treatment with anastrozole presented with bilateral blurry vision, photophobia, and eye soreness. Optical coherence tomography (OCT) of both maculae revealed vitreomacular traction (VMT), an epiretinal membrane, cystoid macular edema (CME) in the right eye, and drusen without subretinal fluid bilaterally. Although later, macular OCT did show evidence of cystoid intraretinal spaces in the left eye as well. Fluorescein angiography showed bilateral petaloid leakage, bilateral slow disc leaking, as well as peripheral leakage in the right eye. Anastrozole was discontinued and, subsequent macular OCT showed release of VMT in the right eye, and eventual resolution of intraretinal cystoid spaces bilaterally.<BR><B>CONCLUSIONS: </B>Stopping of anastrozole was associated in resolution of refractory CME in a patient on aromatase inhibitor therapy for breast cancer. It is therefore important to consider anastrozole and other aromatase inhibitor drugs as possible factors predisposing patients to the development of CME.